Alternative names (1)
hasBlackBoxWarningRandom triples
| Subject | Object |
|---|---|
| gptkb:Axicabtagene_ciloleucel | neurological toxicities |
| gptkb:Cyclophosphamide | secondary malignancies |
| gptkb:Clozaril | agranulocytosis |
| gptkb:Nefazodone | liver failure |
| gptkb:fluoroquinolones | CNS effects |
| gptkb:Zohydro_ER | life-threatening respiratory depression |
| gptkb:relmacabtagene_autoleucel | cytokine release syndrome |
| gptkb:DB08865 | spinal/epidural hematoma risk |
| gptkb:ticagrelor | bleeding risk |
| gptkb:Etanercept | malignancy |
| gptkb:Simponi | serious infections |
| gptkb:Yescarta_(2017) | neurological toxicities |
| gptkb:Cyclophosphamide | bladder toxicity |
| gptkb:DB09278 | risk of hepatitis B reactivation |
| gptkb:CHEMBL511 | false |
| gptkb:DB06690 | spinal/epidural hematoma risk |
| gptkb:Paroxetine | increased risk of suicidal thoughts in young people |
| gptkb:Abilify | suicidal thoughts and behaviors in children, adolescents, and young adults |
| gptkb:trastuzumab_deruxtecan | gptkb:interstitial_lung_disease |
| gptkb:trastuzumab_deruxtecan | embryo-fetal toxicity |